(Q40796017)

23 September 2017

Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain (English)

1 reference

23 September 2017

0 references

1 reference

1 reference

Chauhan NB

1

1 reference

PubMed ID

11429269

23 September 2017

Siegel GJ

series ordinal

2

1 reference

PubMed ID

11429269

23 September 2017

Lee JM

series ordinal

3

1 reference

23 September 2017

1 June 2001

1 reference

Journal of Chemical Neuroanatomy

23 September 2017

1 reference

23 September 2017

21

1 reference

23 September 2017

4

1 reference

23 September 2017

277-288

1 reference

trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

A commentary on glial cell line-derived neurotrophic factor (GDNF). From a glial secreted molecule to gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

GDNF is an age-specific survival factor for sensory and autonomic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Differential expression of Na,K-ATPase alpha-isoform mRNAs in aging rat cerebellum.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

A Drosophila model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Functional recovery in parkinsonian monkeys treated with GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Tyrosine hydroxylase and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Biochemistry of Parkinson's disease with special reference to the dopaminergic systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Immunocytochemical localization of GDNF in primary afferents of the lumbar dorsal horn

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

The intermolecular disulfide bridge of human glial cell line-derived neurotrophic factor: its selective reduction and biological activity of the modified protein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Trophic protection of motor neurons: clinical potential in motor neuron diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line--derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical con

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Intrastriatal Infusions of Brain-Derived Neurotrophic Factor: Retrograde Transport and Colocalization with Dopamine Containing Substantia Nigra Neurons in Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Medial nigral dopamine neurons have rich neurotrophin support in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Trauma-induced striatal CNTF and BDNF mRNA in hemiparkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Regional and cell-specific expression of GDNF in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Neurotrophic factors in Alzheimer's and Parkinson's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Expression of GDNF mRNA in rat and human nervous tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Maintaining the neuronal phenotype after injury in the adult CNS. Neurotrophic factors, axonal growth substrates, and gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Growth factors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

GDNF: a novel factor with therapeutic potential for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

Growth Factors Rescue Embryonic Dopamine Neurons from Programmed Cell Death

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900115-6

7 January 2021

10.1016/S0891-0618(01)00115-6

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

11429269